Investing Profile

Kyle Kurpinski(3)


tenx.tcSan Francisco, California
Photo of Kyle Kurpinski, Partner at Tencent Holdings

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
University of California, Berkeley Network
University of Michigan Network
Tencent Holdings Partner
$100K - $30.0M
CompanyStageDateRound SizeTotal Raised
Series AMar 2018$45M
Co-investors: Raj Ganguly (B Capital Group), Matt Ocko (DCVC (Data Collective)), Kiersten Stead (DCVC (Data Collective)), Xinhong Lim (Vickers Venture Partners), David E. Weekly (, Stefano Bernardi, Farzad Nazem
Locus Biosciences
Series ANov 2017$19M
Co-investors: Stuart Peterson
Guardant Health
Series EMay 2017$360M
Series DJan 2016$100M
Co-investors: Samir Kaul (Khosla Ventures), Chris Schaepe (Lightspeed Venture Partners), Pejman Nozad (Pear VC), John Lee (Jazz Venture Partners), Bobby Yazdani (Cota Capital), David Chen, Farzad Nazem
Clear Labs
Series BDec 2016$16.3M
Co-investors: Aydin Senkut (Felicis Ventures), Greg Yap (Menlo Ventures), Krishna Yeshwant (GV)
Color Genomics
Series BSep 2016$45M
Co-investors: Chris Farmer (SignalFire), Katie Stanton (Moxxie Ventures)
Series AOct 2015$13.1M
Co-investors: Dovey Wan (Danhua Capital)
Oscar Health
Series CApr 2015$145M
Co-investors: Brian Singerman (Founders Fund), Joel Cutler (General Catalyst), Peter Thiel (Founders Fund), David Tisch (BoxGroup), Adam Rothenberg (BoxGroup), Joshua Kushner (Thrive Capital)
Seed RoundSep 2014
Co-investors: Sundeep Peechu (Felicis Ventures), Samuel Lessin (Slow Ventures), Sunil Dhaliwal (Amplify Partners), Andrew Boszhardt (Great Oaks Venture Capital), Charles Hudson (Precursor Ventures), Henry McNamara (Great Oaks Venture Capital), Paul Buchheit (Y Combinator), Kenny Van Zant, Joe Greenstein
I'm most interested in companies building deep core technologies to solve complex challenges in human health and planetary resiliency. I'm particularly drawn towards data-driven companies, and I focus heavily on those innovating at the intersection of data science and life science. I'm intrigued by the possibilities of using robotics, automation, miniaturization, and new high-throughput techniques to rapidly generate novel and actionable insights for users.
I generally do not invest companies that lack a clear and defensible core technology.
University of California, Berkeley PhD Bioengineering
University of Michigan BS Chemical Engineering